Data Support Use of Adjuvant Chemotherapy in Upper Tract Urothelial Cancer
Updated results from the phase 3 POUT trial support the use of adjuvant chemotherapy in patients with upper tract urothelial cancer, according to researchers.
Annual Breast Cancer Screening From Ages 40 to 79 Years Is Best Strategy
Annual screening appears to provide the greatest benefit and lowest risk.
Black-Box Warnings for CAR-T Therapies Unlikely to Change Clinical Practice
The black box warnings are unlikely to deter clinicians from prescribing CAR-T therapies, largely because these patients frequently have few other options.
Risk of Financial Toxicity Shared by Caregivers and BMT Patients With Hematologic Cancer
Patients with hematologic cancer and their caregivers are at risk of financial toxicity, especially in the bone marrow transplantation setting.
Historical Redlining, Contemporary Mortgage Discrimination Linked to Breast Cancer Outcomes
Researchers found that historical redlining and contemporary mortgage discrimination were associated with breast cancer outcomes, but associations varied by race.
Site of Cancer Metastasis May Impact COVID-19 Outcomes
Cancer patients with metastasis are more likely to have poor outcomes of COVID-19, and the site of metastasis impacts outcomes, research suggests.
Delayed Melanoma Care During Pandemic Proved Costly
Delayed diagnoses due to pandemic lockdowns tied to years of life lost.
Digital Health Technology Empowers Patients, Caregivers in Symptom Management
Researchers explored the dynamics of the relationship patients with cancer and their caregivers develop with digital health technology during treatment.
Pembrolizumab Plus Chemotherapy Under Review for Primary Advanced or Recurrent Endometrial Cancer
The sBLA is supported by data from the phase 3 NRG-GY018 trial, which included patients with stage III-IV or recurrent endometrial carcinoma whose cancer was either pMMR or dMMR.
COVID-19 Disrupts Chemo in Kids With ALL, Lymphoblastic Lymphoma
COVID-19 often disrupts chemotherapy in pediatric patients with acute lymphoblastic leukemia or lymphoblastic lymphoma, data suggest.
- Loading...
